The analysis of the range of antihistamines at the pharmaceutical market of Ukraine
DOI:
https://doi.org/10.24959/sphhcj.23.293Keywords:
antihistamines; analysis of the range of antihistaminesAbstract
Aim. To analyze the range of antihistamines (AH) at the pharmaceutical market of Ukraine.
Materials and methods. The analysis of the range of drugs was carried out in accordance with the State Register of Medicines of Ukraine as of February 2023, the weekly “Apteka” to determine the data of actual sales of AH. Statistical, frequency and graphic methods were used in the analysis. The information was processed using Microsoft Office Excel.
Results. As a result of the frequency analysis, it was found that the pharmaceutical market of Ukraine as of February 2023 of AН for systematic use was represented by 170 trade names (TN) and 135 international non-proprietary names (INN). The leaders by INN were Desloratadine (34 TN) and Levocetirizine (26 TN). According to the State Register of Medicines of Ukraine as of February 2023, there were different drug forms, namely: tablets, solutions, drops, syrups, dragees and granules for the preparation of oral suspension. The largest share was AH in the form of tablets (70.59 %), solutions, drops, and syrups accounted for almost the same percentage (10 %, 9,41 %, 8,82 %), and 2 % of AH were registered in the form of dragees. The ratio of AH producing countries at the pharmaceutical market of Ukraine by TN was also determined. It was found that among the dosage forms presented, 62 % were of foreign production. AH of domestic production were 38 %; moreover, the largest market share (19 %) was produced by LLC Pharmaceutical Company “Zdorovye”. According to the results of the official data of weekly “Apteka” on the actual consumption of AH, it was found that AH of the second generation were the most popular both by INN and TN. It is due to their pharmacokinetic properties and the optimal price/effectiveness ratio.
Conclusions. Based on the above, we can conclude that the pharmaceutical market of Ukraine is represented by a wide range of AH in various forms of production and various manufacturers. This leads to a wide choice of drugs of this group among the population, pharmaceutical and medical professionals.
References
Vsesvitnia orhanizatsiia ohorony zdorov’ia. Available at: http://www.who.int.
European Academy of Allergy and Clinical Immunology (EAACI). Tackling the Allergy Crisis in Europe – Concerted Policy Action Needed: Advocacy Manifesto. Available at: http://www.eaaci.org/images/media/ EAACI Manifesto brochure Interactive.pdf.
Bobruk, V. P., Blahun, O. D. (2016). Vinnytsia National Medical University Bulletin, 20 (1 (1)).
Tarasenko, H. V., Selezko, V. S. (2020). Scientific Collection “InterConf”, 37: with the Proceedings of the 1st International Scientific and Practical Conference «Recent Scientific Investigation». (pp. 812-819). Oslo, Norway: Dagens naeringsliv forlag,
Kubarieva, I. V., Puzak, N. O. (2019). Proceeding from Formuvannia natsionalnoi likárskoi polityky za umov vprovadzhennia medychnoho strakhuvannia: pytannia osvity, teorii ta praktyky : materialy V Vseukr. nauk.-osvitnoi Internet konf. (12-13 berez. 2019 r.). (pp. 242-244). Kharkiv: NFaU.
Derzhavnyi reiestr likarskykh zasobiv. Available at: http://www.drlz.com.ua/ibp/ddsite.nsf/all/shlist?opendocument.
Kirsanov, D. (2023). Shchotyzhnevyk “Apteka”. Available at: https://www.apteka.ua/article/665150.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
